Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
Brazil
BR1220190261547
Filed on 2002-05-22
BR1220190261547
Filed on 2002-05-22
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE
US Patent 11,273,214
Filed on 2019-11-25
Filed on 2019-11-25
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE
Japan
2019-565890
Filed on 2018-05-29
2019-565890
Filed on 2018-05-29
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE
European Patent
18733056.8
Filed on 2018-05-29
18733056.8
Filed on 2018-05-29
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE
China
201880048358.8
Filed on 2018-05-29
201880048358.8
Filed on 2018-05-29
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE
Canada
3064267
Filed on 2018-05-29
3064267
Filed on 2018-05-29
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
The Netherlands
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Italy
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Ireland
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
United Kingdom
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18